Association Between Copayment Amount and Filling of Medications for Angiotensin Receptor Neprilysin Inhibitors in Patients With Heart Failure

Background Angiotensin receptor neprilysin inhibitors (ARNI) reduce mortality and hospitalization for patients with heart failure. However, relatively high copayments for ARNI may contribute to suboptimal adherence, thus potentially limiting their benefits. Methods and Results We conducted a retrosp...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American Heart Association Vol. 11; no. 24; p. e027662
Main Authors:	Mukhopadhyay, Amrita, Adhikari, Samrachana, Li, Xiyue, Dodson, John A., Kronish, Ian M., Shah, Binita, Ramatowski, Maggie, Chunara, Rumi, Kozloff, Sam, Blecker, Saul
Format:	Journal Article
Language:	English
Published:	England John Wiley and Sons Inc 20.12.2022 Wiley
Subjects:	Angiotensin Receptor Antagonists - therapeutic use angiotensin receptor‐neprilysin inhibitor Biphenyl Compounds - therapeutic use copayment Drug Combinations Heart Failure Humans medication adherence Neprilysin - antagonists & inhibitors Original Research out‐of‐pocket cost Retrospective Studies sacubitril‐valsartan Stroke Volume Tetrazoles - therapeutic use Treatment Outcome Valsartan - therapeutic use Ventricular Function, Left heart failure medication adherence out‐of‐pocket cost sacubitril‐valsartan angiotensin receptor‐neprilysin inhibitor copayment
ISSN:	2047-9980, 2047-9980
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!